Newborn screening for metabolic disorders: How are we doing, and where are we going?

Clinical Chemistry

Volumn 58, Issue 2, 2012, Pages 324-331

  Bennett, Michael J ^a   Rinaldo, Piero ^b   Wilcken, Bridget ^c   Pass, Kenneth A ^d   Watson, Michael S ^e   Wanders, Ronald J A ^f  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b MAYO CLINIC   (United States)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d International Society for Newborn Screening   (United States)

^e American Society for Medical Genetics   (United States)

^f University Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE;

CLINICAL LABORATORY; EARLY DIAGNOSIS; HUMAN; LABORATORY TEST; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE DEFICIENCY; METABOLIC DISORDER; NEWBORN; NEWBORN SCREENING; NOTE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCREENING TEST; TANDEM MASS SPECTROMETRY;

BIOLOGICAL MARKERS; HUMANS; INFANT, NEWBORN; METABOLIC DISEASES; MICROARRAY ANALYSIS; NEONATAL SCREENING; POSTNATAL CARE; PRACTICE GUIDELINES AS TOPIC;

EID: 84856371498     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.171215     Document Type: Note

References (0)